Vaccination against Chlamydia Genital Infection Utilizing the Murine C. muridarum Model

CM Farris, RP Morrison - Infection and immunity, 2011 - Am Soc Microbiol
Chlamydia trachomatis genital infection is a worldwide public health problem, and
considerable effort has been expended on developing an efficacious vaccine. The murine …

Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes

AG Lössl, MT Waheed - Plant biotechnology journal, 2011 - Wiley Online Library
Infectious diseases represent a continuously growing menace that has severe impact on
health of the people worldwide, particularly in the developing countries. Therefore, novel …

[HTML][HTML] Vaccine adjuvant properties of probiotic bacteria

PV Licciardi, MLK Tang - Discovery medicine, 2011 - discoverymedicine.com
Vaccine-preventable diseases are still responsible for the deaths of more than 1 million
children under the age of 5 years annually, mostly in developing countries. A substantial …

Archaeosomes with encapsulated antigens for oral vaccine delivery

Z Li, L Zhang, W Sun, Q Ding, Y Hou, Y Xu - Vaccine, 2011 - Elsevier
Traditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily
degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery …

A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors

C Cheng, P Jain, I Bettahi, S Pal, D Tifrea… - Vaccine, 2011 - Elsevier
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen in
the World and there is an urgent need for a vaccine to prevent these infections. To determine …

Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine

DF Tifrea, G Sun, S Pal, G Zardeneta, MJ Cocco… - Vaccine, 2011 - Elsevier
The native major outer membrane protein (nMOMP) from Chlamydia was purified in its
trimeric form using the zwitterionic detergent Z3-14. In aliquots from this preparation, Z3-14 …

Formulation design considerations for oral vaccines

J Wilkhu, SE McNeil, DJ Kirby, Y Perrie - Therapeutic delivery, 2011 - Taylor & Francis
Whilst oral vaccination is a potentially preferred route in terms of patient adherence and
mass vaccination, the ability to formulate effective oral vaccines remains a challenge. The …

Nanocarriers for transmucosal vaccine delivery

S Jain, K Khomane, AK Jain, P Dani - Current nanoscience, 2011 - ingentaconnect.com
Immunization has been realized as one of the most cost effective methods of controlling
microbial infections. Currently, the most widely employed means of vaccine delivery …

Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats

M Pravetoni, DE Keyler, MD Raleigh, AC Harris… - Biochemical …, 2011 - Elsevier
Preclinical models of nicotine vaccine pharmacology have relied on iv or sc administration of
nicotine. Models using cigarette smoke inhalation might more accurately simulate nicotine …

Th17 cells contribute to nontypeable Haemophilus influenzae‐specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α …

K Noda, S Kodama, S Umemoto, N Nomi… - Microbiology and …, 2011 - Wiley Online Library
Nasal vaccination is an effective therapeutic means of preventing upper respiratory infection.
Recently, nasal vaccination with P6 outer membrane protein of nontypeable Haemophilus …